Type(s) of hormonal therapy-Aromatase inhibitors-Letrozole (Femara) Posts on Medivizor
Navigation Menu

Type(s) of hormonal therapy-Aromatase inhibitors-Letrozole (Femara) Posts on Medivizor

Comparing the real-world effectiveness of palbociclib plus letrozole versus letrozole alone in patients with advanced hormone-positive breast cancer

Comparing the real-world effectiveness of palbociclib plus letrozole versus letrozole alone in patients with advanced hormone-positive breast cancer

Posted by on May 16, 2021 in Breast cancer | 0 comments

In a nutshell This study compared the real-world safety and effectiveness of the palbociclib (Ibrance) plus letrozole (Femara) versus letrozole alone in patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor-negative (HER2-) metastatic breast cancer (MBC). The data concluded that palbociclib in combination with...

Read More

Incidence of ovarian function recovery in women over 40 with chemotherapy induced amenorrhea

Posted by on Mar 13, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated ovarian function recovery (OFR) after chemotherapy-induced amenorrhea (absence of menstruation) in women aged 40-49 after 2 years of aromatase inhibitor (AI) therapy. The study concluded that a large number of women with chemotherapy-induced amenorrhea recover ovarian function during AI therapy.  Some...

Read More
ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE
FROM OUR BLOG
LATEST NEWS
CONNECT WITH US
© 2024 Medivizor